$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

$foxo Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023024912 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$13.00K	$420.0K	$511.0K
YoY Change
Cost Of Revenue	$13.00K	$340.0K	$511.0K
YoY Change	-67.5%		325.83%
Gross Profit	$0.00	$70.00K	$167.0K
YoY Change	-100.0%		39.17%
Gross Profit Margin	0.0%	16.67%	32.68%
Selling, General & Admin	$6.332M	$11.60M	$27.20M
YoY Change	163.9%	2114.08%	1987.63%
% of Gross Profit		16571.43%	16285.03%
Research & Development	$309.0K	$890.0K	$3.047M
YoY Change	-48.59%	58.93%	-37.55%
% of Gross Profit		1271.43%	1824.55%
Depreciation & Amortization	$929.0K	$1.330M	$1.487M
YoY Change	2896.77%	4333.33%	1417.35%
% of Gross Profit		1900.0%	890.42%
Operating Expenses	$7.405M	$22.58M	$40.33M
YoY Change	208.61%	4209.82%	2996.14%
Operating Profit	-$7.392M	-$22.51M	-$40.17M
YoY Change	62.0%		167.23%
Interest Expense	$225.0K	-$25.52M	$1.440M
YoY Change	-88.87%	-1632.87%	-75.8%
% of Operating Profit
Other Income/Expense, Net	$2.081M	-$60.00K	$5.649M
YoY Change	-4262.0%	-71.43%	-2493.64%
Pretax Income	-$7.639M	-$48.07M	-$95.26M
YoY Change	1926.42%	-4313.23%	-2149.42%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.639M	-$48.07M	-$95.26M
YoY Change	1926.42%	-4313.23%	-2149.42%
Net Earnings / Revenue	-58761.54%	-11445.24%	-18640.9%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.28	-$1.75	-$3.46
COMMON SHARES
Basic Shares Outstanding	29.56M shares	31.19M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.160M	$5.520M	$5.520M
YoY Change	1017.26%	764.89%	764.89%
Cash & Equivalents	$2.155M	$5.515M	$5.520M
Short-Term Investments
Other Short-Term Assets	$107.0K	$114.0K	$5.470M
YoY Change	-31.77%	-51.34%	2235.01%
Inventory	$1.302M	$1.313M	$1.310M
Prepaid Expenses	$2.117M	$2.686M
Receivables
Other Receivables
Total Short-Term Assets	$6.276M	$12.30M	$12.30M
YoY Change	1692.37%	1310.22%	1309.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$1.863M	$2.043M
YoY Change		969.63%
Long-Term Investments
YoY Change
Other Assets	$1.730M	$21.06M	$21.06M
YoY Change			-5.18%
Total Long-Term Assets	$3.597M	$23.10M	$23.11M
YoY Change	-98.21%	-88.52%	-88.52%
TOTAL ASSETS
Total Short-Term Assets	$6.276M	$12.30M	$12.30M
Total Long-Term Assets	$3.597M	$23.10M	$23.11M
Total Assets	$9.873M	$35.41M	$35.41M
YoY Change	-95.1%	-82.48%	-82.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.977M	$3.466M	$3.470M
YoY Change	49.86%	1019.93%	1021.24%
Accrued Expenses	$1.212M	$1.045M	$1.540M
YoY Change			285.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$3.370M	$1.410M	$1.410M
YoY Change
Total Short-Term Liabilities	$8.585M	$6.913M	$6.910M
YoY Change	291.73%	2098.21%	2097.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$1.730M	$1.730M
YoY Change
Other Long-Term Liabilities	$1.320M	$20.06M	$20.06M
YoY Change	-87.01%	65.34%	65.34%
Total Long-Term Liabilities	$1.320M	$21.79M	$21.79M
YoY Change	-87.01%	79.6%	79.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.585M	$6.913M	$6.910M
Total Long-Term Liabilities	$1.320M	$21.79M	$21.79M
Total Liabilities	$9.903M	$28.70M	$28.70M
YoY Change	-19.82%	130.58%	130.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$154.9M	-$147.2M
YoY Change		1171.97%
Common Stock		$3.000K
YoY Change		4661.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares		2.141M shares
Shareholders Equity	-$30.00K	$6.708M	$6.710M
YoY Change
Total Liabilities & Shareholders Equity	$9.873M	$35.41M	$35.41M
YoY Change	-95.1%	-82.48%	-82.48%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$7.639M	-$48.07M	-$95.26M
YoY Change	1926.42%	-4313.23%	-2149.42%
Depreciation, Depletion And Amortization	$929.0K	$1.330M	$1.487M
YoY Change	2896.77%	4333.33%	1417.35%
Cash From Operating Activities	-$3.360M	-$5.300M	-$23.76M
YoY Change	421.01%	1327.42%	2948.85%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$140.0K	$110.0K
YoY Change		-12.5%	-6.78%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities		-$140.0K	-$1.870M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$30.56M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		500.0K	$24.29M
YoY Change
NET CHANGE
Cash From Operating Activities	-$3.360M	-5.300M	-$23.76M
Cash From Investing Activities		-140.0K	-$1.870M
Cash From Financing Activities		500.0K	$24.29M
Net Change In Cash	-$3.360M	-4.940M	-$1.341M
YoY Change		1230.46%
FREE CASH FLOW
Cash From Operating Activities	-$3.360M	-$5.300M	-$23.76M
Capital Expenditures	$0.00	$140.0K	$110.0K
Free Cash Flow	-$3.360M	-$5.440M	-$23.87M
YoY Change		923.9%	2560.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	foxo	Corporate And Other CorporateAndOther	-30199000	usd
CY2022Q4	foxo	Undesignated Preferred Stock UndesignatedPreferredStock		usd
CY2021Q4	foxo	Undesignated Preferred Stock UndesignatedPreferredStock		usd
CY2021Q4	foxo	Undesignated Preferred Stock Shares Issued UndesignatedPreferredStockSharesIssued		shares
CY2021Q4	foxo	Undesignated Preferred Stock Shares Outstanding UndesignatedPreferredStockSharesOutstanding		shares
CY2022Q4	foxo	Nonredeemable Preferred Stock NonredeemablePreferredStock		usd
CY2022Q4	foxo	Common Stock Value1 CommonStockValue1		usd
CY2021Q4	foxo	Common Stock Value1 CommonStockValue1		usd
CY2021Q4	foxo	Common Stock Value2 CommonStockValue2		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39783
CY2022	dei	Entity Registrant Name EntityRegistrantName	FOXO TECHNOLOGIES INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1050265
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	729 N. Washington Ave
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
CY2022	dei	City Area Code CityAreaCode	(612)
CY2022	dei	Local Phone Number LocalPhoneNumber	562-9447
CY2022	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	FOXO
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	104119693.74	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29558830	shares
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5515000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6856000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1313000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	295000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2686000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	444000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2676000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	114000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	23000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12304000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7618000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2043000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	18573000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	19463000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2225000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2745000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	263000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	287000	usd
CY2022Q4	us-gaap	Assets Assets	35408000	usd
CY2021Q4	us-gaap	Assets Assets	30304000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3466000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3456000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	500000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1409000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1045000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	493000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	402000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	9967000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	22236000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6913000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36061000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	311000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1730000	usd
CY2022Q4	foxo	Policy Reserves PolicyReserves	18573000	usd
CY2021Q4	foxo	Policy Reserves PolicyReserves	19463000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	1173000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	28700000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	55524000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2140761	shares
CY2021Q4	foxo	Undesignated Preferred Stock Par Value UndesignatedPreferredStockParValue	0.00001
CY2021Q4	foxo	Undesignated Preferred Stocksshare Authorized UndesignatedPreferredStocksshareAuthorized	90000000	shares
CY2021Q4	foxo	Nonredeemable Preferred Stock NonredeemablePreferredStock	21854000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153936000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4902000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147231000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51976000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6708000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-25220000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35408000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30304000	usd
CY2022	us-gaap	Revenues Revenues	511000	usd
CY2021	us-gaap	Revenues Revenues	120000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	344000	usd
CY2022	us-gaap	Gross Profit GrossProfit	167000	usd
CY2021	us-gaap	Gross Profit GrossProfit	120000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3047000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4879000	usd
CY2022	foxo	Management Contingent Share Plans ManagementContingentSharePlans	10091000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27196000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10272000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	40334000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	15151000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-40167000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-15031000	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-28180000	usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-21703000	usd
CY2022	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative	2076000	usd
CY2022	foxo	Forward Purchase Agreement Expenses ForwardPurchaseAgreementExpenses	27337000	usd
CY2022	us-gaap	Interest Expense InterestExpense	1440000	usd
CY2021	us-gaap	Interest Expense InterestExpense	1118000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	400000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-207000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-236000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-55088000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-23457000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-95255000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-38488000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95255000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-38488000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8720000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38488000	usd
CY2021	foxo	Lease Contributions LeaseContributions	547000	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	238000	usd
CY2021	foxo	Subscriptions Received SubscriptionsReceived	3750000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	13000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-25220000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45437000	usd
CY2022	foxo	Lease Contributions LeaseContributions	225000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	716000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-507000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6900000	usd
CY2022	foxo	Conversion Of Bridge Loans ConversionOfBridgeLoans	88975000	usd
CY2022	foxo	Conversion Of Existing Class A Common Stock ConversionOfExistingClassACommonStock	1000	usd
CY2022	foxo	Reverse Recapitalization ReverseRecapitalization	19689000	usd
CY2022	foxo	Net Loss After Business Combination NetLossAfterBusinessCombination	-49818000	usd
CY2022	foxo	Equitybased Compensations EquitybasedCompensations	10364000	usd
CY2022	foxo	Cantor Commitement Fee CantorCommitementFee	1600000	usd
CY2022	foxo	Verndor Shares Issuance VerndorSharesIssuance	376000	usd
CY2022	foxo	Share Repurchase And Forward Purchase Agreement Settlement ShareRepurchaseAndForwardPurchaseAgreementSettlement	-1156000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6708000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95255000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-38488000	usd
CY2022	us-gaap	Depreciation Depreciation	1487000	usd
CY2021	us-gaap	Depreciation Depreciation	98000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1370000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	400000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	11035000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	131000	usd
CY2022	foxo	Cantor Commitment Fee CantorCommitmentFee	1600000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	270000	usd
CY2022	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	26773000	usd
CY2022	foxo	Vendor Share Issuance Paid In Common Stock VendorShareIssuancePaidInCommonStock	376000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	4679000	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	28180000	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	21703000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2076000	usd
CY2022	foxo	Conversion Of Accrued Interest ConversionOfAccruedInterest	593000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	130000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	91000	usd
CY2022	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments	225000	usd
CY2021	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments	547000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28000	usd
CY2022	foxo	Accretion Of Operating Lease Liabilities AccretionOfOperatingLeaseLiabilities	28000	usd
CY2022	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption	107000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	32000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	14000	usd
CY2022	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	1018000	usd
CY2021	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	295000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2832000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-117000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	91000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	6000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	100000	usd
CY2022	foxo	Cloud Computing Arrangements CloudComputingArrangements	1773000	usd
CY2021	foxo	Cloud Computing Arrangements CloudComputingArrangements	2488000	usd
CY2022	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	890000	usd
CY2021	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	305000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	127000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3090000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2336000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	154000	usd
CY2022	foxo	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	890000	usd
CY2021	foxo	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	305000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23760000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15055000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	110000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	63000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	1760000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	124000	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	50000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1870000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-355000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3250000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	28000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7250000	usd
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	507000	usd
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	3458000	usd
CY2022	foxo	Reverse Recapitalization Proceeds ReverseRecapitalizationProceeds	23237000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-30561000	usd
CY2022	foxo	Forward Purchase Agreement Collateral Release To Meteora ForwardPurchaseAgreementCollateralReleaseToMeteora	2362000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	540000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	107000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1160000	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	3750000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24289000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14143000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1341000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1267000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6856000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8123000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6856000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	54000	usd
CY2021	us-gaap	Transfer To Investments TransferToInvestments	1000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	88382000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	21854000	usd
CY2022	foxo	Accrued Internal Use Software AccruedInternalUseSoftware	239000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1219000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1131000	usd
CY2022	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	95255000	usd
CY2022	foxo	Retained Earning Appropriated RetainedEarningAppropriated	147231000	usd
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	23760000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	513000	usd
CY2022Q1	us-gaap	Convertible Debt ConvertibleDebt	28000000	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	28000000	usd
CY2022Q4	us-gaap	Other Partners Capital OtherPartnersCapital	300000000	usd
CY2022Q4	foxo	Longevity Pipeline LongevityPipeline	576000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">USE OF ESTIMATES</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations and various other assumptions that management believes are reasonable under the circumstances. It is reasonably possible that actual experience could differ from the estimates and assumptions utilized. All revisions to accounting estimates are recognized in the period in which the estimates are revised. A description of each critical estimate is incorporated within the discussion of the related accounting policies which follow.</p><p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q4	foxo	Longevity Pipeline LongevityPipeline	75000	usd
CY2022Q4	foxo	Underwriting Api UnderwritingAPI	770000	usd
CY2021Q4	foxo	Underwriting Api UnderwritingAPI	53000	usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	400000	usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	100000	usd
CY2021	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	100000	usd
CY2022Q4	foxo	Contract Assets contractAssets	200000	usd
CY2022Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	100000	usd
CY2022	foxo	Other Asset OtherAsset	100000	usd
CY2022	foxo	Longevity Api LongevityAPI	697000	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	2043000	usd
CY2021Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	191000	usd
CY2022	us-gaap	Revenues Revenues	511000	usd
CY2021	us-gaap	Revenues Revenues	120000	usd
CY2022	foxo	Percenatge Of Commissions Earned PercenatgeOfCommissionsEarned	0.80	pure
CY2022Q1	foxo	Percentage Of Commission And Fee Revenues PercentageOfCommissionAndFeeRevenues	0.15	pure
CY2022	foxo	Percentage Of Commission And Fee Revenues PercentageOfCommissionAndFeeRevenues	0.05	pure
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	63000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2225000	usd
CY2022	foxo	Percentage Of Coinsurance Agreement PercentageOfCoinsuranceAgreement	1	pure
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	63000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2745000	usd
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1307000	usd
CY2022	foxo	Senior Notes Percentage SeniorNotesPercentage	0.15	pure
CY2022Q3	foxo	Senior Notes Percentage SeniorNotesPercentage	0.15	pure
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3458000	usd
CY2022Q3	foxo	Net Proceeds NetProceeds	2918000	usd
CY2022Q3	us-gaap	Exchange Fees ExchangeFees	540000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.15	pure
CY2022	foxo	Interest Percentage InterestPercentage	1150	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1409000	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	130000	usd
CY2021Q1	foxo	Original Issue Discount OriginalIssueDiscount	0.125	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	1.30	pure
CY2022	foxo	Company Loan Description CompanyLoanDescription	The Company loaned Delwinds $387 per month in June 2022, July 2022, and August 2022 prior to the Closing of the Business Combination.
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	500000	usd
CY2022Q2	foxo	Agreement Term Period AgreementTermPeriod	P12M
CY2022Q2	foxo	Exchange Fees1 ExchangeFees1	1425000	usd
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	871256	shares
CY2022	us-gaap	Other Expenses OtherExpenses	5649000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	80000	shares
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.0001
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	510000000	shares
CY2022	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	10000000	shares
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022	foxo	Warrants Description WarrantsDescription	Once the warrants become exercisable, the Company may redeem the Public Warrants: ●in whole and not in part; ●at a price of $0.01 per warrant; ●upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and ●if, and only if, the reported last sale price of the Company’s Class A Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	300000	shares
CY2022	foxo	Shares Subject To Equitable Adjustment SharesSubjectToEquitableAdjustment	9200000	shares
CY2022	foxo	Timebased Vesting Description TimebasedVestingDescription	Each restricted share award shall be subject to three service-based vesting conditions: a)Sixty percent (60%) of a participant’s restricted share award will become vested on the third anniversary of the Closing if the participant is still employed by the company on such date (and has been continuously employed by the company from the date of grant through such vesting date). b)An additional twenty percent (20%) of a participant’s restricted share award will become vested on the fourth anniversary of the Closing if the participant is still employed by the company on such date (and has been continuously employed by the company from the date of grant through such vesting date). c)The final twenty percent (20%) of a participant’s restricted share award will become vested on the fifth anniversary of the Closing if the participant is still employed by the company on such date (and has been continuously employed by the company from the date of grant through such vesting date).
CY2021	foxo	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Values ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValues	0.59
CY2022	foxo	Share Based Compensation Shares Authorized Under Stock Option Plans ShareBasedCompensationSharesAuthorizedUnderStockOptionPlans	2765099	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	17425	shares
CY2022	foxo	Share Based Compensation Arrangement Additional Stock Options ShareBasedCompensationArrangementAdditionalStockOptions	204181	shares
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	54000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2828307	shares
CY2022	foxo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Values SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValues	6.51
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	204181	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.75
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14796	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.51
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	252593	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	8.36
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2765099	shares
CY2022	foxo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Averages Grant Date Fair Values SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAveragesGrantDateFairValues	7.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2480991	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.7
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M1D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y2M12D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.943	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0138	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0024	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	foxo	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Values ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValues	15.75
CY2022	foxo	Research And Development ResearchAndDevelopment	110000	usd
CY2021	foxo	Research And Development ResearchAndDevelopment	-19000	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	834000	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	150000	usd
CY2022	foxo	Total Equity Based Compensation Expense TotalEquityBasedCompensationExpense	944000	usd
CY2021	foxo	Total Equity Based Compensation Expense TotalEquityBasedCompensationExpense	131000	usd
CY2022Q4	us-gaap	Investment Owned Unrecognized Unrealized Depreciation InvestmentOwnedUnrecognizedUnrealizedDepreciation	1105000	usd
CY2022	foxo	Purchase Agreement PurchaseAgreement	29135000	usd
CY2022	foxo	Reset Price Percentage ResetPricePercentage	0.925	pure
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.05
CY2022Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	500000	shares
CY2022Q4	foxo	Fair Value Additional Expanse FairValueAdditionalExpanse	270000	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	4348000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-95255000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-38488000	usd
CY2021Q4	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	4646698	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	10378750	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1905853	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1905853	shares
CY2022Q4	foxo	Assumed Option Shares AssumedOptionShares	2965500	shares
CY2021Q4	foxo	Assumed Option Shares AssumedOptionShares	2965500	shares
CY2022Q4	foxo	Total Antidilutive Shares TotalAntidilutiveShares	15250103	shares
CY2021Q4	foxo	Total Antidilutive Shares TotalAntidilutiveShares	16277693	shares
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	311000	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	32203000	usd
CY2021	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.52	pure
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10500000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	21703000	usd
CY2021Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	32203000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	28000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	28180000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	88383000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-88383000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	9767000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3372000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4054000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1613000	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	13821000	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	4985000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	13821000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	4985000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	51334000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2022	foxo	Effective Income Tax Rate Fair Value Adjustments On Convertible Debentures EffectiveIncomeTaxRateFairValueAdjustmentsOnConvertibleDebentures	-0.071	pure
CY2021	foxo	Effective Income Tax Rate Fair Value Adjustments On Convertible Debentures EffectiveIncomeTaxRateFairValueAdjustmentsOnConvertibleDebentures	-0.149	pure
CY2022	foxo	Forward Purchase Agreement Percent ForwardPurchaseAgreementPercent	-0.085	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.145	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.13	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3817000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	38000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17193000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7885000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1270000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	130000	usd
CY2021	foxo	Deferred Tax Assests Issuance Fees On Convertible Debentures DeferredTaxAssestsIssuanceFeesOnConvertibleDebentures	25000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22287000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8078000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21837000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8027000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	450000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	51000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	450000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	51000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	450000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	51000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	59688000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1642000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	58046000	usd
CY2022	us-gaap	Business Combination Price Of Acquisition Expected BusinessCombinationPriceOfAcquisitionExpected	1155000	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	63000	usd
CY2022Q4	us-gaap	Cash Cash	1092000	usd
CY2022	foxo	Reinsure Policies ReinsurePolicies	1	pure
CY2022	foxo	Reinsured Business Percentage ReinsuredBusinessPercentage	1	pure
CY2022Q4	foxo	Policy Reserves PolicyReserves	18573000	usd
CY2021Q4	foxo	Policy Reserves PolicyReserves	19463000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	362000	usd
CY2022	us-gaap	Ceded Premiums Earned CededPremiumsEarned	1349000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	108000	usd
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	523000	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	5000000	usd
CY2022	foxo	Riskbased Capital Percentage RiskbasedCapitalPercentage	3.01	pure
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	5000000	usd
CY2022	us-gaap	Reinsurance Retention Policy Reinsured Risk Percentage ReinsuranceRetentionPolicyReinsuredRiskPercentage	1	pure
CY2022	foxo	Statutory Net Loss StatutoryNetLoss	105000	usd
CY2021	foxo	Statutory Net Loss StatutoryNetLoss	29000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	62000	usd
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	65000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits Life LiabilityForFuturePolicyBenefitsLife	14246000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits Life LiabilityForFuturePolicyBenefitsLife	14746000	usd
CY2021Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	4717000	usd
CY2020Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	4816000	usd
CY2022	foxo	Deposits Received DepositsReceived	7000	usd
CY2021	foxo	Deposits Received DepositsReceived	3000	usd
CY2022	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	139000	usd
CY2021	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	87000	usd
CY2022	foxo	Withdrawals Withdrawals	-536000	usd
CY2021	foxo	Withdrawals Withdrawals	-189000	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	4327000	usd
CY2021Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	4717000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	511000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	120000	usd
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	6504000	usd
CY2021	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	7171000	usd
CY2022	foxo	Corporate And Other CorporateAndOther	-87311000	usd
CY2022	foxo	Interest Expense Earnings InterestExpenseEarnings	-1440000	usd
CY2021	foxo	Interest Expense Earnings InterestExpenseEarnings	-1118000	usd
CY2022	us-gaap	Revenues Revenues	511000	usd
CY2021	us-gaap	Revenues Revenues	120000	usd
CY2022	us-gaap	Distributed Earnings DistributedEarnings	95255000	usd
CY2021	us-gaap	Distributed Earnings DistributedEarnings	38488000	usd
CY2022	foxo	Consulting Agreement Expense ConsultingAgreementExpense	17708000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1487000	usd
CY2022	foxo	Changes In Fair Value Of Convertible Debentures Warrant Liability And Forward Purchase Derivative ChangesInFairValueOfConvertibleDebenturesWarrantLiabilityAndForwardPurchaseDerivative	26104000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	1307000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	27544000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	131000	usd
CY2021	foxo	Change In Fair Value Of Convertible Debentures ChangeInFairValueOfConvertibleDebentures	98000	usd
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	21703000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2022	foxo	Purchase Units PurchaseUnits	10000	shares
CY2022	foxo	Supply Commitment Remaining SupplyCommitmentRemaining	3000	shares
CY2022Q4	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	92000	usd
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	146000	usd
CY2022	foxo	Outstanding Balance Percentage OutstandingBalancePercentage	0.125	pure
CY2022	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	6207000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	576000	usd
CY2022Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	999000	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	8695000	usd
CY2022Q4	us-gaap	Shares Issued SharesIssued	50000	shares
CY2022	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	The Company is responsible for payments up to $849 related to the agreement, half of which was paid upon contract execution during the second quarter of 2022. Remaining payments are due as follows: (i) 20% upon the enrollment of the first patient, (ii) 20% upon the enrollment of the final patient and (iii) 10% upon lab receipt of shipments for all initially planned assays. In addition to the $424 payment upon execution, the Company incurred $272 of other costs related to VECTOR. Costs associated with the clinical trial agreement are being recorded as research and development expenses in the consolidated statements of operations.
CY2022	us-gaap	Reinsurance Retention Excess Retention Amount Reinsured Per Life ReinsuranceRetentionExcessRetentionAmountReinsuredPerLife	200000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Notes Payable NotesPayable		usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q4	foxo	Common Stock Value2 CommonStockValue2		usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021	foxo	Management Contingent Share Plans ManagementContingentSharePlans		usd
CY2021	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative		usd
CY2021	foxo	Forward Purchase Agreement Expenses ForwardPurchaseAgreementExpenses		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	foxo	Conversion Of Class B Common Stock ConversionOfClassBCommonStock		usd
CY2021	foxo	Cantor Commitment Fee CantorCommitmentFee		usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2021	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability		usd
CY2021	foxo	Vendor Share Issuance Paid In Common Stock VendorShareIssuancePaidInCommonStock		usd
CY2021	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization		usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021	foxo	Conversion Of Accrued Interest ConversionOfAccruedInterest		usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2021	foxo	Accretion Of Operating Lease Liabilities AccretionOfOperatingLeaseLiabilities		usd
CY2021	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption		usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2021	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt		usd
CY2021	foxo	Reverse Recapitalization Proceeds ReverseRecapitalizationProceeds		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	foxo	Forward Purchase Agreement Collateral Release To Meteora ForwardPurchaseAgreementCollateralReleaseToMeteora		usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	us-gaap	Transfer To Investments TransferToInvestments		usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2021	foxo	Accrued Internal Use Software AccruedInternalUseSoftware		usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance		usd
CY2021	foxo	Longevity Api LongevityAPI		usd
CY2022Q4	foxo	Excess Stock Shares Issued1 ExcessStockSharesIssued1		shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q4	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares		shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued		shares
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		usd
CY2021	foxo	Forward Purchase Agreement Percent ForwardPurchaseAgreementPercent		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet		usd
CY2022	foxo	Deferred Tax Assests Issuance Fees On Convertible Debentures DeferredTaxAssestsIssuanceFeesOnConvertibleDebentures		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001812360

Files In Submission

Name	View Source	Status
foxo-20221231_lab.xml	Edgar Link	unprocessable
0001213900-23-024912-index-headers.html	Edgar Link	pending
0001213900-23-024912-index.html	Edgar Link	pending
0001213900-23-024912.txt	Edgar Link	pending
0001213900-23-024912-xbrl.zip	Edgar Link	pending
f10k2022ex21-1_foxotech.htm	Edgar Link	pending
f10k2022ex31-1_foxotech.htm	Edgar Link	pending
f10k2022ex31-2_foxotech.htm	Edgar Link	pending
f10k2022ex32-1_foxotech.htm	Edgar Link	pending
f10k2022ex4-4_foxotech.htm	Edgar Link	pending
f10k2022_foxotech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
foxo-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
foxo-20221231_cal.xml	Edgar Link	unprocessable
foxo-20221231_def.xml	Edgar Link	unprocessable
foxo-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_foxotech_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

2023 Q1 Form 10-K Financial Statement

#000121390023024912 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO FOXO TECHNOLOGIES INC. Stock $foxo

2023 Q1 Form 10-K Financial Statement

#000121390023024912 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo